SCHEMBL4344840

SCHEMBL4344840

Cn1cnc(NC(=O)c2ccc(F)cc2)c1C(=O)NN

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.45
KCNQ3 O43525 1/20 0.44
KCNQ2 O43526 1/20 0.44
KCNE1 P15382 1/20 0.44
KCNQ1 P51787 1/20 0.44
BACE1 P56817 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
PTPN1 P18031 2/20 0.43
P4HTM Q9NXG6 1/20 0.43
KDM4E B2RXH2 1/20 0.43
NPC1 O15118 3/20 0.43
CXCR1 P25024 1/20 0.43
CXCR2 P25025 1/20 0.43
ATM Q13315 1/20 0.43
FLT1 P17948 1/20 0.42
KDR P35968 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MITF O75030 1/20 0.42
PTPN6 P29350 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4201013 0.74 SMN1; SMN2 (0.48) RAB9ASMN1; SMN2KDM4ENPC1MEN1
SCHEMBL4196359 0.72 MEN1 (0.45) RAB9AKCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL4249220 0.72 PTPN1 (0.73) RAB9AKCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL7985361 0.72 P2RY14 (0.52) KDM4EALDH1A1
SCHEMBL7985255 0.71 ALDH1A1 (0.51) RAB9ASMN1; SMN2KDM4ENPC1MEN1
SCHEMBL9908251 0.71 MPO (0.64) PTPN1KDM4EMEN1KMT2AMITF
SCHEMBL222973 0.71 MPO (0.64) PTPN1KDM4EMEN1KMT2AMITF
SCHEMBL7973823 0.70 NPC1 (0.48) RAB9AKDM4ENPC1CXCR2KDR
SCHEMBL7991372 0.70 NR1H4 (0.49) ALDH1A1
SCHEMBL11840654 0.69 MEN1 (0.60) RAB9AKCNQ3KCNQ2KCNE1KCNQ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105124-A1 HETEROCYCLIC MODULATORS OF TGR5 KALYPSYS, INC. (US) 2009-04-23 US disclosed
US-20090105124-A1 HETEROCYCLIC MODULATORS OF TGR5 KALYPSYS, INC. (US) 2009-04-23 US disclosed
US-20090105124-A1 HETEROCYCLIC MODULATORS OF TGR5 KALYPSYS, INC. (US) 2009-04-23 US disclosed
WO-2009026241-A1 HETEROCYCLIC MODULATORS OF TGR5 KALYPSYS, INC. (US) 2009-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105124-A1 HETEROCYCLIC MODULATORS OF TGR5 GPBAR1, GPR119, GRK5 RAB9A 2224/4885KCNQ3 2429/4885KCNQ2 2565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.